Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 European best practice guidelines 5: target haemoglobin.

Literature DB >> 11052145

European best practice guidelines 5: target haemoglobin.

C Jacobs, W H Hörl, I C Macdougall, F Valderrábano, I Parrondo, A Segner, I L Abraham.

Abstract

Mesh：

Substances：
Hemoglobins

Year: 2000 PMID： 11052145

Source DB: PubMed Journal: Nephrol Dial Transplant ISSN： 0931-0509 Impact factor: 5.992

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Aiming at averages.

Authors: E J Will
Journal: J R Soc Med Date: 2001-12 Impact factor: 5.344

2. Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients.

Authors: Georgios Bristoyiannis; Nikolaos Germanos; Dimitrios Grekas; Christos Hatzidimitriou; Christos Iatrou; Dimitrios Memmos; Spiros Moutafis; Konstantinos Papachristoforou; Antonis Papadoniou; Michalis Pappas; George A Sakellariou; Kostas C Siamopoulos; Konstantinos Sombolos; Kiriaki Stamatelou; Charalambos P Stathakis; Georgios Stavgiannoudakis; Spiros Stratigis; Christos Syrganis; Dimitris Tsakiris; Dimitris Valis; Jannis G Vlahojannis; Dimosthenis Vlassopoulos
Journal: Curr Ther Res Clin Exp Date: 2005-05

3. A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.

Authors: Loreto Gesualdo; Gérard London; Matthew Turner; Christopher Lee; Karen Macdonald; David Goldsmith; Adrian Covic; Philippe Zaoui; Christian Combe; Johannes Mann; Frank Dellanna; Michael Muenzberg; Ivo Abraham
Journal: Intern Emerg Med Date: 2011-05-18 Impact factor: 3.397

European best practice guidelines 5: target haemoglobin.

1. Aiming at averages.

2. Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients.

3. A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.

4. A study of the response of elderly patients with end-stage renal disease to epoetin alfa or beta.

Review 5. Erythropoietic stress and anemia in diabetes mellitus.

Review 6. Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease.